Editorial comment on: Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells

Eur Urol. 2007 Dec;52(6):1680-1. doi: 10.1016/j.eururo.2007.01.098.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Humans
  • Male
  • Neoplasm Invasiveness
  • Prostatic Neoplasms / chemistry*
  • Prostatic Neoplasms / pathology
  • Trypsin Inhibitor, Kazal Pancreatic / analysis*
  • Trypsinogen / physiology

Substances

  • Trypsin Inhibitor, Kazal Pancreatic
  • Trypsinogen